Loading…
Back To Schedule
Wednesday, June 27 • 4:00pm - 5:15pm
#383: Safe Use and Prescribing of Opioid Medications: An In-Depth Look at the Strategies and Their Evaluation

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-674-L04-P; CME 1.25; IACET 1.25; RN 1.25

Prescription opioids can be used to treat moderate-to-severe pain, such as pain following surgery or injury, in health conditions such as cancer, and in chronic, non-cancer conditions such as back pain or osteoarthritis. More than 25 million Americans suffer from daily chronic pain, and prescription opioid therapy has been instrumental in helping patients manage their symptoms and achieve a better quality of life. However, it is estimated that more than 2 million Americans have opioid use disorder (OUD), and that millions more misuse opioids, taking these medications longer or in higher doses than prescribed. The problem has reached a level of crisis, as an average of 115 Americans die each day from an overdose of opioids, either prescription or heroin. According to CDC statistics, the number of overdose deaths involving opioids increased five-fold from 1999 to 2016, driven largely by prescription opioids.

These alarming increases in opioid-related harms have mobilized the US health system to implement strategies to support safe use and appropriate prescribing behaviors. This session will examine the framework and current strategies for a well-balanced approach aimed at reducing the supply of opioids vulnerable to misuse and mitigating risks through more judicious prescribing. Panelists will discuss the critical need and ways to assess the impact of these strategies on patient health outcomes and public health in order to avoid creating barriers to appropriate treatment for both acute and chronic pain.

Learning Objectives

Describe strategies to promote the safe use and prescribing of opioids within a framework balancing safe prescribing and appropriate pain management, risk mitigation, and patient access; Discuss how strategies can be implemented and determine how success may be defined and measured.

Chair

Sidney H. Schnoll

Speaker

Safe Use of Opioids: FDA Perspective
Gerald J. Dal Pan, MD, MHS

Opiates: A Patient Experience
Alton Johnson, PhD, RPh

Clinician/Drug Development Perspective
Veeraindar Goli

Prescribing Opioid Medicines for Patients
Daniel P Alford, MD, MPH, FACP


Speakers
DA

Daniel Alford

Professor of Medicine, Director, Clinical Addiction Research and Education (CARE, Boston University School of Medicine, Boston Medical Center
Daniel P. Alford, MD, MPH is Professor of Medicine, Associate Dean of Continuing Medical Education and Director of the Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program at Boston University School of Medicine. He is on staff in the Section of General Internal... Read More →
VG

Veeraindar Goli

Senior Director, CNS Center of Excellence; Emeritus Professor, Duke University, IQVIA
Thirty-nine years of experience as a physician. Triple boarded in Pain Medicine, Addiction Medicine, and Psychiatry. Medical Director, Pain Evaluation and Treatment Services, at Duke University Medical Center until 2008. MBA , Fuqua School of Business , Duke University, Durham, NC... Read More →
avatar for Alton Johnson

Alton Johnson

Vice President, Global Technology Services, Pfizer Inc
Alton Johnson is VP Global Technology Services leading Technology & Business Solutions function in Pfizer Global Supply. He has over 30 years of experience in new product development & launch, technology transfer, clinical supplies, marketed product support, PAT, and advanced manufacturing... Read More →
avatar for Gerald Dal Pan

Gerald Dal Pan

Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Gerald J. Dal Pan, MD, MHS currently serves as the Director of the Office of Surveillance and Epidemiology in FDA’s Center for Drug Evaluation and Research, where since 2005 he has been responsible for the Center’s programs in adverse event surveillance and analysis, pharmacoepidemiology... Read More →
SS

Sidney Schnoll

Vice President, Pharmaceutical Risk Management, Pinney Associates, Inc

Wednesday June 27, 2018 4:00pm - 5:15pm EDT
Room 253C Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  01: ClinSafety-PV, Session